Aurigene Pharmaceutical Services plans $40M biotherapeutics facility in Hyderabad

Aurigene Pharmaceutical Services, a subsidiary of Dr. Reddy's Laboratories, announced a $40 million investment to build a production facility for therapeutic proteins, antibodies and viral vectors at Genome Valley in Hyderabad, India. The facility is expected to be fully operational by the first half of 2024.

“With this expansion in biotherapeutics CDMO, we will be positioned to provide integrated services from clinical research to commercial manufacturing for small and large molecules.”fiercepharma.com

• 1 source
• fiercepharma.comDr. Reddy's subsidiary Aurigene plans $40M expansion in IndiaJoseph KeenanMay 25, 2023

Summarized from public sources; check the original articles before acting on it.